Infectious : Actualité Infectious en direct - P2 | Bourse Reflex
Accueil > Tags > Infectious

  • Toutes les actualités en rapport avec « Infectious »

05/01 19:00 Infectious - Genticel appoints Rémi Palmantier, PhD, as Chief Scientific Officer to accelerate its development

10/12 18:15 Infectious - Disclosure of the total number of voting rights and shares composing the share capital

02/12 18:00 Infectious - Benedikt Timmerman resumes CEO position at Genticel

29/10 18:00 Infectious - Genticel Announces First Patient Treated in U.S. Phase 1 Clinical Trial of GTL001, Company's Therapeutic Vaccine Candidate against HPV 16/18 Infections

28/10 18:45 Infectious - Business Update - Third Quarter 2015

28/09 18:00 Infectious - Disclosure of the total number of voting rights and shares composing the share capital

21/09 17:40 Infectious - Genticel presents first half 2015 financial results, operational progress and outlook

08/09 07:30 Infectious - US patent granted for use of Genticel's antigen delivery vectors in combination therapy to treat cancer

01/09 18:00 Infectious - GENTICEL to meet investors

28/07 18:00 Infectious - Business Update - Second Quarter 2015

07/07 18:00 Infectious - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

03/07 18:00 Infectious - Summary of Genticel's liquidity contract with Oddo Corporate Finance

02/07 18:15 Infectious - Genticel CFO, Martin Koch, Appointed CEO to Replace Benedikt Timmerman during Temporary Medical Leave of Absence

16/06 07:00 Infectious - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

01/06 07:00 Infectious - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

21/05 18:00 Infectious - Documents Available for Annual General Meeting of Shareholders

28/04 19:00 Infectious - Business Update - First Quarter 2015

23/04 18:00 Infectious - Genticel to Participate in SmallCap Event on April 27 - 28 in Paris, France

20/04 18:40 Infectious - Genticel to Present Further Promising Pharmacology In-Vivo Results of its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015

09/04 19:20 Infectious - Genticel strengthens management team and appoints Valerie Leroy as Senior Director, Corporate Communications and Investor Relations